Skip to content

Inpatient Versus Outpatient Diagnosis of Gastric Adenocarcinoma: Differences in Stage, Risk Factors, and Surgical Outcomes.

Aug 2026 · The American surgeon · pp. 31348261484508 · 0 citations · 22 references
Medicine

TL;DR

Patients diagnosed with gastric cancer in the inpatient setting represent a distinct cohort not captured by risk indicators that prompt opportunistic endoscopic evaluation in the absence of US screening guidelines, and subgroups may benefit from targeted screening.

Abstract

PurposeThere is no standard gastric cancer screening in the United States. To understand populations at risk, we describe patients by diagnosis setting.MethodsSingle-institution, retrospective cohort study (2016-2023). Adults who underwent surgery for gastric adenocarcinoma.ResultsPatients with inpatient diagnoses of gastric cancer (n = 29) were less likely to be Asian (62% vs 82%, P = 0.009) or have family history (17% vs 45%, P = 0.006), and more likely to have non-curative surgery (24% vs 2%, P < 0.001), higher pathological stage (54% vs 23%, P = 0.002), lymphovascular invasion (52% vs 21%, P = 0.005), longer length of stay (8 days [IQR 5.5-16.5] vs 5 days [IQR 4.0-7.0], P < 0.001), and 90-day postoperative complications (40% vs 21%, P = 0.048).ConclusionPatients diagnosed with gastric cancer in the inpatient setting represent a distinct cohort not captured by risk indicators (family history, East Asian ancestry, prior H. pylori) that prompt opportunistic endoscopic evaluation in the absence of US screening guidelines. Subgroups may benefit from targeted screening.

View source

Similar papers

Open access Sep 2026

Surgery of gallbladder carcinoma: current standards validated on a European cohort

Current recommendations for GBC surgery are validated, emphasizing the importance of adherence to achieve optimal outcomes, and high morbidity in advanced resections, R0 status remains crucial.

Marc A. Reschke, S. Schmitz, Anja Gallinat et al. · 0 citations
Open access Oct 2026

Survival Outcomes in Hepatocellular Carcinoma: A Decade of Treatment in a Western Tertiary Referral Center.

BACKGROUND & AIMS Hepatocellular carcinoma (HCC) remains a challenging malignancy with various available treatments. This retrospective study provides clinical outcomes on staging, treatment, and overall survival (OS) of HCC patients. METHODS All included patients were diagnosed between 2013 and 2022. OS was assessed...

P. E. van der Meeren, L. Beuk, G. Milinovic et al. · 0 citations
Review Open access Oct 2026

Financial Toxicity in Patients with Resected Esophageal Cancer.

BACKGROUND Esophagectomy for esophageal cancer is associated with significant morbidity and can result in financial hardship, yet this aspect of survivorship remains understudied. This study evaluated the prevalence and risk factors of financial toxicity (FT) among patients following esophagectomy. METHODS Patients w...

Nathaniel Deboever, M. Eisenberg, N. Zhou et al. · 0 citations
Sep 2026

Development of Benchmark Values for Evaluating Outcomes in Patients Undergoing Gallbladder Cancer Surgery in China: A Multicenter Retrospective Cohort Study.

BACKGROUND Surgery is the only potentially curative treatment for gallbladder cancer (GBC); however, existing surgical benchmarks are derived mainly from Western populations and exclude some complex clinical presentations, limiting regional comparisons. METHODS This multicenter retrospective cohort study evaluated pa...

Ru-Yi Wang, Bai-Wen Dong, Yu-Le Luo et al. · 0 citations
Open access Sep 2026

Geographic and clinical predictors of one-day discharge after radical prostatectomy: a SEER-Medicare cohort study

Objectives: To study the geographic patterns, temporal trends, and predictors of one-day discharge following radical prostatectomy. Methods: We conducted a retrospective cohort study of men diagnosed with prostate cancer from 2008 to 2019 in the Surveillance, Epidemiology, and End Results (SEER)-Medicare linked databas...

J. Hanna, M. Shanahan, J. Sykes et al. · 0 citations
Open access Oct 2026

Impact of Neoadjuvant Chemotherapy on Pathological Outcomes and Survival in Muscle-Invasive Bladder Cancer: A Single-Center Retrospective Analysis

Neoadjuvant chemotherapy (NAC) is recommended for patients with muscle-invasive bladder cancer (MIBC); however, its impact on survival outcomes remains controversial in real-world clinical settings. This retrospective observational study evaluated the effect of NAC on pathological outcomes and overall survival among pa...

Ibrahim Topcu, Bulut Dural, Ö. Yıldırım et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.